β-Amyloid as a new target to suppress tonic PTH hypersecretion in primary hyperparathyroidism., PMID:40492090
Use of burosumab in McCune Albright syndrome: case report and review of literature in mosaic disorders with FGF23 overproduction., PMID:40491596
Novel Aptamers Targeting Sclerostin Loop3 Improve Skeletal and Muscle Properties Without Adverse Cardiovascular Effects in Orchiectomized Mice., PMID:40464222
Monitoring denosumab therapy using the calcium isotope marker (CIM) technology., PMID:40374024
Biased antibodies and beyond: a new era in the diagnosis of PTH-dependent hypercalcemia., PMID:40335290
Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort., PMID:40323576
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia., PMID:40314226
Burosumab treatment of a child with McCune-Albright syndrome/polyostotic fibrous dysplasia: challenges and benefits., PMID:40297189
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay., PMID:40295688
[Changes in circulating levels of calcium and bone metabolism biochemical markers in patients receiving denosumab treatment]., PMID:40294926
Graphitic carbon nitride/1-pyrenebutyric acid N-hydroxysuccinimide/polythiophene nanocomposite photoelectrochemical biosensor for CA 19-9 detection., PMID:40253965
Effects of asfotase alfa on fracture healing of adult patient with hypophosphatasia and literature review., PMID:40189581
Selective modulation of the bone remodeling regulatory system through orthodontic tooth movement-a review., PMID:40115506
Effect of a single-dose denosumab on mineral homeostasis in infertile men: insights from a pilot intervention study and a randomized controlled trial., PMID:40055742
A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade., PMID:40020675
Trypanosoma cruzi has Two Peptidyl-tRNA Hydrolases Showing Different Localization and Function., PMID:39945942
Burosumab Treatment in a Girl With Cutaneous Skeletal Hypophosphatemia Syndrome: 2-Year Follow-Up., PMID:39925163
Non-parathyroid hypercalcemia in a patient with new-onset hyperthyroidism and silicone-induced granulomas: case report., PMID:39906031
Aptamer-Antibody Birecognized Sandwich SERRS Biosensor in Accurate and Rapid Identification of Intraoperative Parathyroid Hormone., PMID:39880691
Parathyroid hormone levels following denosumab vs. zoledronic acid therapy for osteoporosis., PMID:39863008
Bone Health ECHO Case Report: Significant Elevation in Bone Turnover Markers and Progression of Vertebral Fractures After Denosumab Discontinuation Followed by a PTH-Analog., PMID:39731882
An Unlabeled Electrochemical Immunosensor Uses Poly(thionine) and Graphene Quantum Dot-Modified Activated Marigold Flower Carbon for Early Prostate Cancer Detection., PMID:39727854
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda., PMID:39706666
PTH immunoassay interference: differential diagnosis with normocalcemic primary hyperparathyroidism?, PMID:39529983
Rebound hypercalcemia after denosumab cessation during follow-up after surgical treatment for parathyroid carcinoma: case report and literature review., PMID:39529981
Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies., PMID:39519190
Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment., PMID:39515508
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk., PMID:39494453
Analysis of vitamin D metabolism, thyroid and autoimmune markers in the vitiligo pathways and their possible interaction with sleep., PMID:39485538
Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?, PMID:39453203
Multiple Reaction Monitoring-Mass Spectrometric Immunoassay Analysis of Parathyroid Hormone Fragments with Vitamin D Deficiency in Patients with Diabetes Mellitus., PMID:39449502
Latest on Anabolic Agents for Osteoporosis Treatment., PMID:39448133
Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect., PMID:39424806
Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab., PMID:39384494
Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling., PMID:39376604
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports., PMID:39340538
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report., PMID:39289209
Are we closer to achieving precision medicine for migraine treatment? A narrative review., PMID:39256924
Mechanistic Insights and Therapeutic Strategies in Osteoporosis: A Comprehensive Review., PMID:39200100
[The role of immunohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of parathyroid glands]., PMID:39073536
Burosumab treatment of X-linked hypophosphatemia patients: interim analysis of the SUNFLOWER longitudinal, observational cohort study., PMID:39015507
Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature., PMID:38987211
[Effect and safety of Burosumab in the treatment of 4 children with X-linked hypophosphatemia]., PMID:38955688
Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets., PMID:38950880
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?, PMID:38938063
Is denosumab an efficient and safe drug for osteoporosis in dialysis patients? Considerations and state of the art about its use in this setting., PMID:38856936
[Bone mineral density in women with rheumatoid arthritis: A link between immune and biochemical markers]., PMID:38829811
Response to Letter to the Editor From Kawaguchi: "Cardiovascular Safety of Romosozumab vs PTH Analogs for Osteoporosis Treatment: A Propensity Score Matched Cohort Study"., PMID:38767110
Letter to the Editor From Kawaguchi: "Cardiovascular Safety of Romosozumab vs PTH Analogs for Osteoporosis Treatment: A Propensity Score Matched Cohort Study"., PMID:38759101
Non-Classical Effects of FGF23: Molecular and Clinical Features., PMID:38732094
For research use only. Not for human or drug use.
